The global beta nerve growth factor market is anticipated to grow at a significant CAGR 5.9% during the forecast period (2022-2028). NGF beta protein or the nerve growth factor is mainly involved with the maintenance, growth and proliferation of particular target growth neurons. The market growth is majorly attributed to the promising opportunities of clinical use of beta nerve growth factor in Alzheimer’s disease, and Parkinson’s disease patients as well as in peripheral neuropathies. The nerve growth factor is a neurotrophic growth factor called neutrophin which supports growth and elasticity of neurons of the peripheral and central nervous system. According to the National Institute of Environment Health Sciences, over 9.3 million individuals in the US are predicted to be affected with Parkinson’s disease by 2020. Nerve growth factor regulates the growth of the nerve that regulates the sensation of touch, heat and pain.

The market growth is further attributed to the growing prevalence of brain related complications, the growing geriatric population which is more prone to such diseases and various advancements in the neuro related therapy and research. Adding to this, the increasing patient population, increasing awareness of neurological disorders such as amnesia, dementia, and depressions, among others owing to the stressful lifestyles are fueling the global beta nerve growth factor market. Moreover, the investment into this market is drawn by the research on the blocking molecules of nerve growth factors for the therapy of several diseases ranging from the viral infections, to Alzheimer’s disease, and Parkinson’s disease.

Market Coverage

• The market number available for – 2021-2028

• Base year- 2021

• Forecast period- 2022-2028

• Segment Covered- 

o By Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  AstraZeneca plc, Pfizer Inc., and Eli Lilly and Co., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Beta Nerve Growth Factor Market Report by Segment

By Type

• KP-544

• MEDI-7352

• Others

By Application

• Mild Cognitive Impairment

• Optic Nerve Injury

• Sickle Cell Disease

• Others

Global Beta Nerve Growth Factor Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa